Artemisinin attenuates type 2 diabetic cardiomyopathy in rats through modulation of AGE-RAGE/HMGB-1 signaling pathway

Diabetes mellitus is a common metabolic disorder. About two-thirds of diabetic patients develop diabetic cardiomyopathy (DCM), which becomes a challenging issue as it severely threatens the patient’s life. Hyperglycemia and the resulting advanced glycated end products (AGE) and their receptor (RAGE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrag, Eman A. E., Hammad, Maha O., Safwat, Sally M., Hamed, Shereen, Hellal, Doaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329689/
https://www.ncbi.nlm.nih.gov/pubmed/37422477
http://dx.doi.org/10.1038/s41598-023-37678-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329689/
https://www.ncbi.nlm.nih.gov/pubmed/37422477
http://dx.doi.org/10.1038/s41598-023-37678-w

Ejemplares similares